Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients

被引:0
|
作者
M Ruhnke
J Paiva
W Meersseman
J Pachl
I Grigoras
G Sganga
F Menichetti
P Montravers
G Auzinger
G Dimopoulos
M Borges Sá
P Miller
T Marček
M Kantecki
机构
[1] Charité University Hospital,
[2] Hospital São João,undefined
[3] University Hospital Leuven,undefined
[4] University Hospital Královské Vinohrady,undefined
[5] University Hospital Sf Spiridon,undefined
[6] University Hospital A Gemelli,undefined
[7] University Hospital Pisa,undefined
[8] Hospital Bichat Claude Bernard,undefined
[9] King's College Hospital,undefined
[10] University Hospital Attikon,undefined
[11] Hospital Son Llatzer,undefined
[12] Pfizer,undefined
[13] Pfizer,undefined
来源
Critical Care | / 15卷 / Suppl 1期
关键词
Candidiasis; Azole; Global Response; Anidulafungin; Sofa Score;
D O I
10.1186/cc9660
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] PHARMACOECONOMIC ANALYSIS OF ANIDULAFUNGIN, MICAFUNGIN, CASPOFUNGIN AND FLUCONAZOLE IN THE TREATMENT OF CANDIDEMIA AND/OR INVASIVE CANDIDIASIS IN NON-NEUTROPENIC ADULT PATIENTS IN SPAIN
    Grau, S.
    Pozo, J.
    Roma, E.
    Salavert, M.
    Barrueta, J.
    Peral, C.
    Rodriguez, I
    Rubio-Rodriguez, D.
    Rubio-Terres, C.
    VALUE IN HEALTH, 2015, 18 (07) : A584 - A585
  • [2] Cost-effectiveness analysis of anidulafungin for the management of invasive candidiasis in non-neutropenic patients in Mexico
    Mould-Quevedo, J.
    Contreras-Hernandez, I
    Vega-Hernandez, G. Y.
    Davila-Loaiza, G.
    VALUE IN HEALTH, 2008, 11 (03) : A99 - A99
  • [3] Comparison of anidulafungin's and fluconazole's in vivo activity in neutropenic and non-neutropenic models of invasive candidiasis
    Wiederhold, N. P.
    Najvar, L. K.
    Bocanegra, R.
    Kirkpatrick, W. R.
    Patterson, T. F.
    CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (02) : E20 - E23
  • [4] Management of invasive candidiasis in non-neutropenic patient
    Cardozo, Celia
    Mensa, Jose
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2015, 28 : 34 - 37
  • [5] Multifocal candidiasis can be considered a form of invasive candidiasis in critically non-neutropenic patients
    Ibanez-Nolla, Jordi
    Nolla-Salas, Miquel
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2024, 147
  • [6] Invasive candidiasis in the critically ill, patient non-neutropenic
    Schwetz, Ines
    Domej, Wolfgang
    Krause, Robert
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2007, 157 (19-20) : 490 - 492
  • [7] Update on invasive candidiasis in non-neutropenic critically ill adult patients
    Zaragoza, Rafael
    Ramirez, Paula
    Borges, Marcio
    Peman, Javier
    REVISTA IBEROAMERICANA DE MICOLOGIA, 2016, 33 (03): : 145 - 151
  • [8] Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment
    Benoît P. Guery
    Maiken C. Arendrup
    Georg Auzinger
    Élie Azoulay
    Márcio Borges Sá
    Elizabeth M. Johnson
    Eckhard Müller
    Christian Putensen
    Coleman Rotstein
    Gabriele Sganga
    Mario Venditti
    Rafael Zaragoza Crespo
    Bart Jan Kullberg
    Intensive Care Medicine, 2009, 35
  • [9] Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment
    Guery, Benoit P.
    Arendrup, Maiken C.
    Auzinger, Georg
    Azoulay, Elie
    Sa, Marcio Borges
    Johnson, Elizabeth M.
    Mueller, Eckhard
    Putensen, Christian
    Rotstein, Coleman
    Sganga, Gabriele
    Venditti, Mario
    Crespo, Rafael Zaragoza
    Kullberg, Bart Jan
    INTENSIVE CARE MEDICINE, 2009, 35 (02) : 206 - 214
  • [10] Pharmacokinetics of Anidulafungin in Critically Ill Patients with Candidemia/Invasive Candidiasis
    Liu, Ping
    Ruhnke, Markus
    Meersseman, Wouter
    Paiva, Jose Artur
    Kantecki, Michal
    Damle, Bharat
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (04) : 1672 - 1676